🇺🇸 FDA
Patent

US 7244448

Liposomal antineoplastic drugs and uses thereof

granted A61KA61K31/4745A61K45/06

Quick answer

US patent 7244448 (Liposomal antineoplastic drugs and uses thereof) held by Tekmira Pharmaceuticals Corporation expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tekmira Pharmaceuticals Corporation
Grant date
Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4745, A61K45/06, A61K9/127, A61K9/1272